Public R&D investment in economic crises

被引:1
|
作者
Pellens, Maikel [1 ,2 ]
Peters, Bettina [3 ,4 ]
Hud, Martin [5 ]
Rammer, Christian [5 ]
Licht, Georg [5 ]
机构
[1] Katholieke Univ Leuven, ECOOM KU Leuven, Naamsestr 61,box 3551, B-3000 Leuven, Belgium
[2] ZEW Leibniz Ctr European Econ Res Mannheim, Naamsestr 61,box 3551, B-3000 Leuven, Belgium
[3] Univ Luxembourg, ZEW Mannheim, L7,1, D-68161 Mannheim, Germany
[4] Mannheim Ctr Competit & Innovat MaCCI, L7,1, D-68161 Mannheim, Germany
[5] ZEW Mannheim, Mannheim, Germany
关键词
R&D; Public policy; Business cycle; FISCAL-POLICY; PANEL-DATA; DEVELOPMENT SUBSIDIES; CREDIT CONSTRAINTS; BUSINESS CYCLES; INNOVATION; COUNTRIES; GROWTH; RUN; PRODUCTIVITY;
D O I
10.1016/j.respol.2024.105084
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
We study the cyclicality of public R&D in 29 OECD countries over the period 1995 to 2019. Public R&D is procyclical on average, and mostly driven by adjustments in public R&D aimed at the government and higher education sectors. However, public R&D reacts asymmetrically over different phases of the business cycle, becoming acyclical during recessions. This acyclicality masks an important heterogeneity across countries: the world's leading innovators behave countercyclically during recessions and even increase public R&D. These results suggest that countries behind the innovation frontier could still strengthen their resilience to economic crises by adopting countercyclical public R&D strategies, thereby also safeguarding long-term growth through innovation.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Decision frameworks and the investment in R&D
    Baker, Erin
    Olaleye, Olaitan
    Reis, Lara Aleluia
    ENERGY POLICY, 2015, 80 : 275 - 285
  • [42] Knowledge sharing and R&D investment
    Sarkar, Abhirup
    ECONOPHYSICS OF MARKETS AND BUSINESS NETWORKS, 2007, : 227 - 232
  • [43] Investigating investment in biopharmaceutical R&D
    Carter, Percy H.
    Berndt, Ernst R.
    DiMasi, Joseph A.
    Trusheim, Mark
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (10) : 673 - 674
  • [44] R&D, investment, and industry dynamics
    Lach, S
    Rob, R
    JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 1996, 5 (02) : 217 - 249
  • [45] Investigating investment in biopharmaceutical R&D
    Percy H. Carter
    Ernst R. Berndt
    Joseph A. DiMasi
    Mark Trusheim
    Nature Reviews Drug Discovery, 2016, 15 : 673 - 674
  • [46] Is R&D a good investment?: Yes!!
    Grayson, T
    IEEE AEROSPACE AND ELECTRONIC SYSTEMS MAGAZINE, 1998, 13 (04) : 2 - 2
  • [47] The size of firms and R&D investment
    Fishman, A
    Rob, R
    INTERNATIONAL ECONOMIC REVIEW, 1999, 40 (04) : 915 - 931
  • [48] CEO power and R&D investment
    Naaman, Christine
    Sun, Li
    ACCOUNTING RESEARCH JOURNAL, 2022, 35 (02) : 160 - 177
  • [49] Match the effort to the R&D investment
    Ibsen, K
    CHEMICAL ENGINEERING PROGRESS, 2006, 102 (01) : 47 - 51
  • [50] Competition and private R&D investment
    Grebel, Thomas
    Nesta, Lionel
    PLOS ONE, 2020, 15 (05):